Europe Approves Abbott CGM Device; FDA Review Underway

5652

The FDA is currently reviewing a continuous glucose monitoring system from Abbott, the “FreeStyle Navigator.” The CGM device, if approved, will join the CGM systems currently offered by Medtronic and Dexcom.

Abbott’s system has already received the European CE (Conformité Européenne) mark of approval, which allows the company to market the device in Europe.

Click here to view/write comments
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.